The differential diagnosis of primary central nervous system lymphoma from glioblastoma multiforme (GBM) is essential due to the difference in treatment strategies.
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The differential diagnosis of primary central nervous system lymphoma from glioblastoma multiforme (GBM) is essential due to the difference in treatment strategies.
This study retrospectively reviewed 77 patients (24 with lymphoma and 53 with GBM)
to identify the stable and distinguishable characteristics of lymphoma and GBM in 18 Ffluorodeocxyglucose (FDG) positron emission tomography (PET) images using a radiomics approach. Three groups of maps, namely, a standardized uptake value (SUV) map, an SUV map calibrated with the normal contralateral cortex (ncc) activity (SUV/ncc map), and an SUV map calibrated with the normal brain mean (nbm) activity (SUV/nbm map), were generated, and a total of 107 radiomics features were extracted from each SUV map. The margins of the ROI were adjusted to assess the stability of the features, and the area under the curve (AUC) of the receiver operating characteristic curve of each feature was compared with the SUVmax to evaluate the distinguishability of the features. Nighty-five radiomics features from the SUV map were significantly different between lymphoma and GBM, 46 features were numeric stable after marginal adjustment, and 31 features displayed better performance than SUVmax. Features extracted from the SUV map demonstrated higher AUCs than features from the further calibrated maps. Tumors with solid metabolic patterns were also separately evaluated and revealed similar results. Thirteen radiomics features that were stable and distinguishable than SUVmax in every circumstance were selected to distinguish lymphoma from glioblastoma, and they suggested that lymphoma has a higher SUV in most interval segments and is more mathematically heterogeneous than GBM. This
A C C E P T E D M A N U S C R I P T
4 study suggested that 18 F-FDG-PET-based radiomics is a reliable noninvasive method to distinguish lymphoma and GBM.
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1 Introduction ‡ Primary central nervous system (CNS) lymphoma is a rare CNS disease in immunocompetent patients, which accounts for approximately 2% of all primary CNS tumors 1 . The definitive diagnosis of CNS lymphoma is essential due to the differences in strategies for surgery, chemotherapy and radiotherapy between CNS lymphomas and other malignant CNS tumors, such as glioblastoma multiforme (GBM) 2, 3 . Although magnetic resonance imaging (MRI) is frequently applied for the initial evaluation of CNS neoplasms, the radiological differentiation of lymphoma from GBM remains difficult (i.e., lymphoma and GBM can both present with a solid enhanced pattern without visible necrosis on T1-weighted contrast enhanced images). 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is an alternative imaging modality that has been utilized for the assessment of CNS disorders 4 . CNS lymphomas usually have a relatively high tumor cell density and increased glucose metabolism, resulting in an increased standardized uptake value (SUV) [5] [6] [7] . Although few studies have investigated the role of 18 F-FDG-PET for distinguishing CNS lymphoma from GBM [8] [9] [10] , the parameters involved in these studies have been mostly restricted to specific features, such as the maximum SUV (SUVmax) and tumor-to-normal contralateral cortex activity (T/N) ratio, which can hardly display the characteristics of the whole tumor. ‡ Abbreviations: AUC, area under the curve; CNS, central nervous system; FDG, fluorodeoxyglucose; GBM, glioblastoma multiforme; GLCM, grey level cooccurence matrix; GLDM, grey level dependence matrix; GLRLM, grey level run length matrix; ICC, intraclass correlation coefficient; IDH, isocitrate dehydrogenase; MRI, magnetic resonance imaging; MTV, metabolic tumor volume; nbm, normal brain mean; ncc, normal contralateral cortex; PET, positron emission tomography; ROC, receiver operating characteristic; ROI, regions of interest; ROIma, region of interest after marginal adjustment; SUV, standardized uptake value; T/N, tumor-to-normal contralateral cortex activity; TLG, total lesion glycolysis.
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Radiomics is a recent emerging technique that extracts high-throughput imaging features to quantitatively describe the characteristics of a tumor, and to investigate the relationship between radiomics features and tumor phenotype 11, 12 . Radiomics based on multimodal MRI images can detect the heterogeneity within brain tumors and has been widely utilized in the noninvasive prediction of clinical manifestation 13 , genetic characteristics 14 and patient prognosis [15] [16] [17] [18] . The 18 F-FDG-PET-based radiomics approach extracts conventional and textural features and has been successfully utilized for differential diagnosis, treatment response prediction, mutation detection of lung 19 , cervical 20 , and nasopharyngeal cancer 21 . Although previous studies have demonstrated the differential MRI characteristics of CNS lymphoma and GBM taking advantage of the radiomics approach [22] [23] [24] [25] [26] [27] , limited studies have focused on differentiation of these two cancers using 18 F-FDG-PET radiomics. This study retrospectively investigates the imaging characteristics of CNS lymphoma and GBM on 18 F-FDG-PET using a radiomics approach, and selects distinguishable radiomics features for the differential diagnosis of CNS lymphoma from GBM noninvasively.
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Patients
This study retrospectively enrolled 77 patients (24 with CNS lymphoma and 53 with GBM) treated at Peking Union Medical College Hospital between January 2010
and October 2018. The inclusion criteria were as follow: 1) age ≥ 18 years old; 2) underwent surgical resection or biopsy with pathology confirmed primary CNS lymphoma or GBM; 3) had a preoperative 18 F-FDG-PET/CT scan of the brain. The exclusion criteria were as follow: 1) a history of brain tumors; 2) suspected or confirmed peripheral lymphomas; 3) treated with corticosteroids, radiotherapy or chemotherapy before surgery; 4) diabetes mellitus (blood glucose ≥ 10 mmol/L); 5) iatrogenic or disease-related immunosuppression. The study has been approved by the institutional review board, and all patients signed an informed consent form.
18 F-FDG-PET/CT Acquisition and Preprocessing
All patients were required to fast for at least 4 h before 18 
Image Segmentation
Tumors were manually segmented by two experienced neurosurgeons who were blinded to the patients' information, and three-dimensional regions of interest (ROIs)
were delimited on 18 
Postprocessing and Feature Extraction
The SUV value of each pixel was calculated with the following formula 28, 29 :
The calculation of SUV was carried out on an in-house software constructed with SimpleITK (http://www.simpleitk.org) 30 and pydicom Three groups of maps, namely, an SUV map, an SUV map with each pixel divided by the normal contralateral cortex (ncc) activity (SUV/ncc map), and an SUV map with each pixel divided by the normal brain mean (nbm) activity (SUV/nbm map), were generated. During the creation of the SUV/nbm map, the skulls were stripped on the CT series and directly resampled with the nearest neighbor algorithm to the PET series.
Features of these three groups of maps were extracted separately with identical parameters.
No further normalization of the brightness level was performed on processed maps.
No resampling was carried out in order to maintain a higher resolution. 
Feature Evaluation
Conventional features including SUVmax, T/N ratio, metabolic tumor volume
(MTV) and total lesion glycolysis (TLG) were calculated and evaluated their performance in differentiating lymphoma and GBM.
The Mann-Whitney U test was performed to test whether a radiomics feature was significantly different between GBM and lymphoma. The discrimination performance of each radiomics feature was evaluated by the area under the curve (AUC) of the receiver operating characteristic (ROC) curve 33 , whose classifier is a single feature threshold-based simple classifier (a decision tree classifier with one decision node). The AUC of the feature 'First order_Maximum' (also known as SUVmax in nonradiomics studies) was used as the threshold for assessing whether a feature was more discriminative than SUVmax.
Marginal Adjustment
To evaluate the robustness of the features and the impact of ROI quality, the edge of the original ROI was expanded with a radius of 2 voxels in all spatial directions (2mm in X-Y plane and 3mm in the Z axis) to generate an ROI after marginal adjustment (ROIma). An example of the marginal adjustment is displayed in Figure 1 .
Radiomics features from the SUV map, SUV/ncc map, and SUV/nbm map from the ROIma were also extracted. Intraclass correlation coefficient (ICC) between the features extracted from the ROI and ROIma in the SUV map were calculated using the variance components from a one-way ANOVA, and features were considered stable if ICC > 0.50 34 .
Analysis of Solid Metabolic Tumors
A solid metabolic tumor was defined as a lesion without a significant necrosis or cysts inside the ROI, which is known as atypical glioblastoma among GBM patients 26 .
Solid metabolic tumors for the whole patient group were manually selected, and their radiomics features from the abovementioned 3 radiomics maps (SUV map, SUV/ncc map and SUV/nbm map) with the two ROIs (initial ROI and ROIma) were and evaluated separately.
Feature Selection and Performance Evaluation
Radiomics features were selected to differentiate lymphoma from GBM if: 1) significantly different between GBM and lymphoma (p < 0.05); 2) relatively stable after marginal adjustment (ICC > 0.50); 3) performed better than 'First order_Maximum' in all 12 situations (in the SUV map, SUV/ncc map and SUV/nbm map with the initial ROI and ROIma, and in the whole population and in solid metabolic tumors). The threshold values of the selected features were calculated. The accuracy, sensitivity, specificity, precision rate, and recall rate of the selected features in the whole population were also calculated to evaluate the differential performances. 
Feature Validation with Machine Learning Approach

Radiomics Map Generation and Differentiation Presentation
The radiomics maps were produced with a 21*21 square mask moving through each pixel in a selected 336*336 pixel layer, making the radiomics map to have 316*316 pixels. At each possible position, a set of radiomics features was calculated with the moving mask and reflected regional radiomics characteristics of the image.
Radiomics maps were further utilized to present the diversities in lymphoma and GBM patients.
Statistical Analysis
All statistical analyses were performed with R 3.5.1 (https://www.r-project.org), scikit-learn 0.20.1 (https://scikit-learn.org) and Python 3.6.6 (https://www.python.org).
The analysis was performed with a normal computer (Intel Core i9-7940x CPU @ 3.1
GHz base frequency, 64 GB RAM, Windows 10).
3 Results 
Patient Characteristics
Differential Performance of Conventional Features
SUVmax, T/N ratio and MTV and TLG were the conventional quantitative features that been evaluated, and they reached the AUC of 0.943, 0.870, 0.707 and 0.608, accuracy of 0.883, 0.844, 0.662 and 0.701 in differentiating CNS lymphoma from GBM, respectively.
Radiomics Feature Evaluation of the Whole Population
The heat map of the 107 radiomics features from the SUV map is shown in Figure   2 and there were also greater number of newly identified features with the two calibrated maps. Features that performed better than 'First order_Maximum' were also ranked by AUC values from each of the three radiomics maps before and after margin adjustment to demonstrate stability, and the rankings are displayed in Supplementary material 3.
Analysis for Solid Metabolic Tumors
The 
Feature Selection and Performance Evaluation
Among the 107 involved radiomics features, 95 were significantly different abovementioned circumstances. Finally, 13 features that met the selection criteria were selected for the noninvasive differential diagnosis of lymphoma and GBM. In the SUV map, the selected radiomics features showed AUCs ranged from 0.971 to 0.998 in distinguish lymphoma and GBM in the whole population, and all of them demonstrated higher accuracy, sensitivity, specificity, precision rate and recall rate than 'First order_Maximum'. The discrimination performance of the selected radiomics features are displayed in Table 2 .
Feature Validation with Machine Learning Approach
The cross-validated AUC values of the 'First order_Maximum' ranged from 0.690 to 0.815 in all of the 6 circumstances with the whole population, which were lower than AUCs without cross-validation. Most of the 13 selected radiomics features displayed a cross-validated AUCs higher than that of the 'First order_Maximum' but also lower than their original AUCs. The 13 features displayed cross-validated AUCs ranging from 0.784 to 0.969 in the SUVmap in the differential diagnosis with the whole population.
The cross-validated AUCs of the selected radiomics features with the whole population under the 6 circumstances are presented in Table 3 .
Differentiation Presentation
One lymphoma and one GBM patient who shared similar metabolic types of tumors
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17 and had comparable SUVmax values were selected for discrimination using radiomics maps. The radiomics maps of these two patients are demonstrated in Figure 4 . The selected features, discrimination threshold values, and values of the selected features in these two patients are detailed in Table 4 .
A C C E P T E D M A N U S C R I P T 18 4 Discussion
Our study demonstrated the distinguishing characteristics of CNS lymphoma and GBM on 18 F-FDG-PET in addition to SUVmax through a radiomics approach. An SUV map, SUV/ncc map, and SUV/nbm map were generated to test the effectiveness of different correction techniques, and 107 radiomics features were extracted from each SUV map. The performance of each radiomics feature was evaluated, and margin adjustments were performed to evaluate the feature stability both in numeric value and in prediction performance. Analysis of solid metabolic tumors was also performed.
Ultimately, 13 radiomics features were selected, revealing the discriminating characteristics of CNS lymphoma and GBM on 18 F-FDG-PET and providing a dependable approach for noninvasive differential diagnosis of CNS lymphoma from GBM. 18 were also excluded due to the inter-reader discrepancy of segmentations. Interestingly, the number of distinguishable features increased after margin adjustment regardless of the calibration method or analyzed population, suggesting that the peri-tumor area may also contain information that can distinguish CNS lymphoma and GBM. Radiomics features in such peri-tumor area as well as the intratumoral habitat regions from multimodal imaging may provide additional information about tumor properties, and the biological processes underlying these imaging features remains to be investigated [35] [36] [37] [38] .
First-order features refer to imaging characteristics exhibited by voxels alone. In dependence matrix (GLDM), which is constructed with a given distance and calculated based on the center voxel. The differences in these 3 GLRLM and GLDM derived features also suggested that GBM was more uniform and homogeneous than lymphoma.
It is also worth mentioning that alternative GLRLM features (e.g., 'GLRLM_Short run emphasiss') are also numeric stable and outperformed 'First order_Maximum' in 11 of the 12 situations and may also be included for distinguishing lymphoma from GBM.
On the other hand, shape features and other texture features (features from the grey level size zone matrix and neighboring grey tone difference matrix) may not be distinguishing characteristics compared with 'First order_Maximum'.
The current study has a few limitations. First, the patient population included in this study was relatively small, and 18 Abbreviations: GLCM, gray-level co-occurrence matrix; GLRLM, gray level run length matrix;
GLDM, gray level dependence matrix. 
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